CTSG and type 1 diabetes mellitus: Additionally, as we demonstrated in immune cells of type 1 diabetes (T1D) patients, high levels of CatG were found and were responsible for insulin antigen processing as well as antigen presentation to activate autoreactive T cells, which can be prevented by the CatG inhibitor (Zou et al., 2011).